Tetra-arsenic oxide (Tetras) enhances radiation sensitivity of solid tumors by anti-vascular effect

Cancer Letters

Volumn 277, Issue 2, 2009, Pages 212-217

  Park, Sae Gwang ^a   Jung, Jeong Joo ^a   Won, Hae Jeong ^a   Kang, Mi Seon ^a   Seo, Su Kil ^a   Choi, Il Whan ^a   Eun, Choong Ki ^a   Ahn, Ki Jung ^a   Park, Cheol Woo ^a   Lee, Soo Woong ^a   Lew, Young S ^b   Bae, Ill Ju ^b   Choi, In Hak ^a  

^a Inje University College of Medicine   (South Korea)

^b Chunjisan Co Ltd   (South Korea)

Author keywords

Caner therapy; Radiation therapy enhancement; Tetra arsenic oxide

Indexed keywords

ARSENIC DERIVATIVE; TETRA ARSENIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SOLID TUMOR; TUMOR GROWTH; TUMOR NECROSIS;

ANGIOGENESIS INHIBITORS; ANIMALS; ARSENICALS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; NEOPLASMS, SQUAMOUS CELL; OXIDES; RADIATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

TETRA;

EID: 62749098229     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.12.012     Document Type: Article

References (22)

1. Kwong Y.L., and Todd D. Delicious poison: arsenic trioxide for the treatment of leukemia. Blood 89 (1997) 3487-3488
2. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89 (1997) 3354-3360
3. Soignet S.L., Frankel S.R., Douer D., Tallman M.S., Kantarjian H., Calleja E., Stone R.M., Kalaycio M., Scheinberg D.A., Steinherz P., Sievers E.L., Coutre S., Dahlberg S., Ellison R., and Warrell Jr. R.P. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J. Clin. Oncol. 19 (2001) 3852-3860
4. Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., and Warrell Jr. R.P. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New Engl. J. Med. 339 (1998) 1341-1348
5. Dai J., Weinberg R.S., Waxman S., and Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93 (1999) 268-277
6. Zhu X.H., Shen Y.L., Jing Y.K., Cai X., Jia P.M., Huang Y., Tang W., Shi G.Y., Sun Y.P., Dai J., Wang Z.Y., Chen S.J., Zhang T.D., Waxman S., Chen Z., and Chen G.Q. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst. 91 (1999) 772-778
7. Kim J.H., Lew Y.S., Kolozsvary A., Ryu S., and Brown S.L. Arsenic trioxide enhances radiation response of 9L glioma in the rat brain. Radiat. Res. 160 (2003) 662-666
8. Lew Y.S., Brown S.L., Griffin R.J., Song C.W., and Kim J.H. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown. Cancer Res. 59 (1999) 6033-6037
9. Griffin R.J., Lee S.H., Rood K.L., Stewart M.J., Lyons J.C., Lew Y.S., Park H., and Song C.W. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors. Neoplasia 2 (2000) 555-560
10. 3). FEBS Lett. 519 (2002) 195-200
11. Griffin R.J., Williams B.W., Park H.J., and Song C.W. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 1516-1522
12. Lew Y.S., Kolozsvary A., Brown S.L., and Kim J.H. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor. Cancer Res. 62 (2002) 4202-4205
13. Fox E., Razzouk B.I., Widemann B.C., Xiao S., O'Brien M., Goodspeed W., Reaman G.H., Blaney S.M., Murgo A.J., Balis F.M., and Adamson P.C. Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. Blood 111 (2008) 566-573
14. Woo S.H., Park M.J., An S., Lee H.C., Jin H.O., Lee S.J., Gwak H.S., Park I.C., Hong S.I., and Rhee C.H. Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF- and VEGF-induced proliferation of human endothelial cells. J. Cell. Biochem. 95 (2005) 120-130
15. Monzen H., Griffin R.J., Williams B.W., Amano M., Ando S., and Hasegawa T. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor. Radiat. Med. 22 (2004) 205-211
16. Reichl F.X., Kreppel H., Szinicz L., Fichtl B., and Forth W. Reduction of arsenic trioxide toxicity in mice by repeated treatment with glucose. Arch. Toxicol. 14 Suppl. (1991) 225-227
17. 6 on cell growth inhibition and gene expression profiles by cDNA microarray analysis in SiHa cells. Oncol. Rep. 12 (2004) 573-580
18. Park I.C., Park M.J., Woo S.H., Lee H.C., An S., Gwak H.S., Lee S.H., Hong S.I., Bae I.J., Seo K.M., and Rhee C.H. Tetraarsenic oxide induces apoptosis in U937 leukemic cells through a reactive oxygen species-dependent pathway. Int. J. Oncol. 23 (2003) 943-948
19. Park M.J., Park I.C., Bae I.J., Seo K.M., Lee S.H., Hong S.I., Eun C.K., Zhang W., and Rhee C.H. Tetraarsenic oxide, a novel orally administrable angiogenesis inhibitor. Int. J. Oncol. 22 (2003) 1271-1276
20. Yoo M.H., Kim J.T., Rhee C.H., Park M.J., Bae I.J., Yi N.Y., Jeong M.B., Jeong S.M., Nam T.C., and Seo K.M. Reverse effects of tetraarsenic oxide on the angiogenesis induced by nerve growth factor in the rat cornea. J. Vet. Med. Sci. 66 (2004) 1091-1095
21. Murata R., Siemann D.W., Overgaard J., and Horsman M.R. Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors. Radiother. Oncol. 60 (2001) 155-161
22. Wilson W.R., Li A.E., Cowan D.S., and Siim B.G. Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. Int. J. Radiat. Oncol. Biol. Phys. 42 (1998) 905-908